
Anna Pagonakis
Examiner (ID: 6985)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1614, 4173, 1609, 1628, OPET |
| Total Applications | 1238 |
| Issued Applications | 444 |
| Pending Applications | 73 |
| Abandoned Applications | 723 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5539810
[patent_doc_number] => 20090221615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'COMBINATION ANTI-CANCER AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/389318
[patent_app_country] => US
[patent_app_date] => 2009-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5287
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221615.pdf
[firstpage_image] =>[orig_patent_app_number] => 12389318
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/389318 | COMBINATION ANTI-CANCER AGENTS | Feb 18, 2009 | Abandoned |
Array
(
[id] => 6202878
[patent_doc_number] => 20110065664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'KINASE PROTEIN BINDING INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/867997
[patent_app_country] => US
[patent_app_date] => 2009-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 20287
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065664.pdf
[firstpage_image] =>[orig_patent_app_number] => 12867997
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/867997 | Kinase protein binding inhibitors | Feb 17, 2009 | Issued |
Array
(
[id] => 4553566
[patent_doc_number] => 07820681
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-10-26
[patent_title] => 'Methods for concomitant administration of colchicine and a second active agent'
[patent_app_type] => utility
[patent_app_number] => 12/372046
[patent_app_country] => US
[patent_app_date] => 2009-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15374
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/820/07820681.pdf
[firstpage_image] =>[orig_patent_app_number] => 12372046
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/372046 | Methods for concomitant administration of colchicine and a second active agent | Feb 16, 2009 | Issued |
Array
(
[id] => 5403566
[patent_doc_number] => 20090238880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'PHOSPHOLIPID-BASED PHARMACEUTICAL FORMULATIONS AND METHODS FOR PRODUCING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/370302
[patent_app_country] => US
[patent_app_date] => 2009-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12842
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20090238880.pdf
[firstpage_image] =>[orig_patent_app_number] => 12370302
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/370302 | PHOSPHOLIPID-BASED PHARMACEUTICAL FORMULATIONS AND METHODS FOR PRODUCING AND USING SAME | Feb 11, 2009 | Abandoned |
Array
(
[id] => 6495208
[patent_doc_number] => 20100009992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'AMPK MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 12/365671
[patent_app_country] => US
[patent_app_date] => 2009-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16270
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20100009992.pdf
[firstpage_image] =>[orig_patent_app_number] => 12365671
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/365671 | AMPK modulators | Feb 3, 2009 | Issued |
Array
(
[id] => 7687421
[patent_doc_number] => 20090176870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'TGF-BETA MODULATORS AND METHODS FOR USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/350976
[patent_app_country] => US
[patent_app_date] => 2009-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7899
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20090176870.pdf
[firstpage_image] =>[orig_patent_app_number] => 12350976
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/350976 | TGF-BETA MODULATORS AND METHODS FOR USING THE SAME | Jan 8, 2009 | Abandoned |
Array
(
[id] => 6263021
[patent_doc_number] => 20100297181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'AMPA Receptor Antagonists for Epilepsy, Mental Disorders or Deficits in Sensory Organ'
[patent_app_type] => utility
[patent_app_number] => 12/744454
[patent_app_country] => US
[patent_app_date] => 2008-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22081
[patent_no_of_claims] => 111
[patent_no_of_ind_claims] => 43
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20100297181.pdf
[firstpage_image] =>[orig_patent_app_number] => 12744454
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/744454 | AMPA Receptor Antagonists for Epilepsy, Mental Disorders or Deficits in Sensory Organ | Dec 25, 2008 | Abandoned |
Array
(
[id] => 6276192
[patent_doc_number] => 20100256191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'AMPA RECEPTOR ANTAGONISTS AND ZONISAMIDE FOR EPILEPSY'
[patent_app_type] => utility
[patent_app_number] => 12/744444
[patent_app_country] => US
[patent_app_date] => 2008-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13640
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256191.pdf
[firstpage_image] =>[orig_patent_app_number] => 12744444
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/744444 | AMPA RECEPTOR ANTAGONISTS AND ZONISAMIDE FOR EPILEPSY | Dec 25, 2008 | Abandoned |
Array
(
[id] => 6599609
[patent_doc_number] => 20100292262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => '4 (PYRROLO[2,3-C]PYRIDINE-3-YL)PYRIMIDIN-2-AMINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/863817
[patent_app_country] => US
[patent_app_date] => 2008-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12793
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20100292262.pdf
[firstpage_image] =>[orig_patent_app_number] => 12863817
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/863817 | 4 (PYRROLO[2,3-C]PYRIDINE-3-YL)PYRIMIDIN-2-AMINE DERIVATIVES | Dec 22, 2008 | Abandoned |
Array
(
[id] => 6389136
[patent_doc_number] => 20100317739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'HISTONE DEACETYLASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/747365
[patent_app_country] => US
[patent_app_date] => 2008-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 23141
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 51
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317739.pdf
[firstpage_image] =>[orig_patent_app_number] => 12747365
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/747365 | Histone deacetylase inhibitors | Dec 11, 2008 | Issued |
Array
(
[id] => 6591295
[patent_doc_number] => 20100130506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'Organic Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/332086
[patent_app_country] => US
[patent_app_date] => 2008-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42943
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20100130506.pdf
[firstpage_image] =>[orig_patent_app_number] => 12332086
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/332086 | Pyrazine-2-carboxamide derivatives to treat diseases mediated by blockade of the epithelial sodium channel | Dec 9, 2008 | Issued |
Array
(
[id] => 5969037
[patent_doc_number] => 20110150873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'ANTI-INFLAMMATORY COMPOSITIONS AND COMBINATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/747878
[patent_app_country] => US
[patent_app_date] => 2008-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9094
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20110150873.pdf
[firstpage_image] =>[orig_patent_app_number] => 12747878
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/747878 | ANTI-INFLAMMATORY COMPOSITIONS AND COMBINATIONS | Dec 9, 2008 | Abandoned |
Array
(
[id] => 6134469
[patent_doc_number] => 20110008371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID FOR TREATMENT OF ANTECEDENT HEMATOLOGIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/747167
[patent_app_country] => US
[patent_app_date] => 2008-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18463
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20110008371.pdf
[firstpage_image] =>[orig_patent_app_number] => 12747167
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/747167 | METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID FOR TREATMENT OF ANTECEDENT HEMATOLOGIC DISORDERS | Dec 9, 2008 | Abandoned |
Array
(
[id] => 5331354
[patent_doc_number] => 20090111831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/331015
[patent_app_country] => US
[patent_app_date] => 2008-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3662
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20090111831.pdf
[firstpage_image] =>[orig_patent_app_number] => 12331015
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/331015 | PHARMACEUTICAL COMPOSITIONS | Dec 8, 2008 | Abandoned |
Array
(
[id] => 5423086
[patent_doc_number] => 20090149542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'COMPOUNDS AND COMPOSITIONS FOR TREATING NEURONAL DEATH OR NEUROLOGICAL DYSFUNCTION'
[patent_app_type] => utility
[patent_app_number] => 12/331040
[patent_app_country] => US
[patent_app_date] => 2008-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 19820
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20090149542.pdf
[firstpage_image] =>[orig_patent_app_number] => 12331040
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/331040 | COMPOUNDS AND COMPOSITIONS FOR TREATING NEURONAL DEATH OR NEUROLOGICAL DYSFUNCTION | Dec 8, 2008 | Abandoned |
Array
(
[id] => 6267291
[patent_doc_number] => 20100298347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'SUBSTITUTED 2-NAPHTHOIC ACIDS AS ANTAGONISTS OF GPR105 ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/743610
[patent_app_country] => US
[patent_app_date] => 2008-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22657
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20100298347.pdf
[firstpage_image] =>[orig_patent_app_number] => 12743610
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/743610 | SUBSTITUTED 2-NAPHTHOIC ACIDS AS ANTAGONISTS OF GPR105 ACTIVITY | Nov 30, 2008 | Abandoned |
Array
(
[id] => 7651940
[patent_doc_number] => 20110301209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER, TUMORS, AND TUMOR-RELATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/132901
[patent_app_country] => US
[patent_app_date] => 2008-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 39131
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301209.pdf
[firstpage_image] =>[orig_patent_app_number] => 13132901
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/132901 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER, TUMORS, AND TUMOR-RELATED DISORDERS | Nov 23, 2008 | Abandoned |
Array
(
[id] => 6402569
[patent_doc_number] => 20100305167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'Administration of an Inhibitor of HDAC'
[patent_app_type] => utility
[patent_app_number] => 12/743557
[patent_app_country] => US
[patent_app_date] => 2008-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 34335
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20100305167.pdf
[firstpage_image] =>[orig_patent_app_number] => 12743557
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/743557 | Administration of an Inhibitor of HDAC | Nov 18, 2008 | Abandoned |
Array
(
[id] => 6499039
[patent_doc_number] => 20100286194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'METHOD FOR TREATING ADDICTION'
[patent_app_type] => utility
[patent_app_number] => 12/743512
[patent_app_country] => US
[patent_app_date] => 2008-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3599
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286194.pdf
[firstpage_image] =>[orig_patent_app_number] => 12743512
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/743512 | METHOD FOR TREATING ADDICTION | Nov 18, 2008 | Abandoned |
Array
(
[id] => 6026358
[patent_doc_number] => 20110053976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'QUINOLINE DERIVATIVES AND THEIR USE AS TYROSINE KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/742944
[patent_app_country] => US
[patent_app_date] => 2008-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6740
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053976.pdf
[firstpage_image] =>[orig_patent_app_number] => 12742944
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/742944 | Quinoline derivatives and their use as tyrosine kinase inhibitors | Nov 13, 2008 | Issued |